Taysha Gene Therapies announces encore presentations on TSHA-102
Taysha Gene Therapies said it has multiple encore presentations supporting its TSHA-102 Rett syndrome clinical program at the 55th Child Neurology Society Annual Meeting.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.